●founderA well-funded consumer brand entering medical imaging at scale could reshape preventive health infrastructure and create platform opportunities around scan data.
●investorMidjourney's pivot into hardware-heavy medical devices is a major capital commitment with long regulatory and deployment timelines — watch for FDA clearance milestones.
●healthUltrasonic CT as a whole-body screening modality is unproven at this scale; clinical validation and regulatory approval will determine whether the billion-scans-per-month target is realistic.